Language selection

Search

2007-01-08 - Male

211644

Adverse reaction report number 211644
Latest AER version number 0
Market authorization holder AER number SPV1200700021
Initial received date 2007-01-08
Latest received date 2007-01-08
Age N/A
Gender Male
Weight N/A
Type of report Spontaneous
Reporter type Physician
Source of report MAH
Report outcome Unknown
Serious report? Yes

Reason for seriousness

Death
Disability
Cogenital anomaly
Life threateting
Hospitalization
Other medically important Yes

Product information

Product description Dosage form Health product role Route of administration Dose Frequency Therapy duration Indication(s)
ADDERALL XRCAPSULE, EXTENDED RELEASESuspectUnknown20 Milligram1 every 1 Day(s)
CLONIDINENOT SPECIFIEDConcomitantUnknown

Adverse reaction term information

MedDRA version: v.21.1
Adverse reaction terms Reaction duration
Seizure
Date modified: